ThePICenter.com: A Nationwide Network of Legal Representation for Accidents and Injuries Home | Refer to a Friend | Contact Us | Attorney Log-In
ThePICenter - The Personal Injury Center  

Call us today: 877.888.5936 
 Cases We Handle  Why Choose Us  About Us  Client Services  Frequently Asked Questions   Free Case Evaluation - Submit Your Case
Abilify
Has Abilify Caused You Or A Loved One Harm?
Fill Out The Form Below For A Free Evaluation
 
Areas of Expertise
Accidents
Consumer Fraud
Medical Malpractice
Toxic Substances
Unsafe Drugs
Unsafe Products
 
Have a case, but would like to speak with us directly?
 
Call us today: 877.888.5936
 
Click here to receive your free evaluation
 
Unsafe Drugs :: Abilify

ABILIFY - WE ARE NO LONGER ACCEPTING ABILIFY INQUIRIES OR CASES!

In late 2003 the Food and Drug Administration approved the use of the drug Aripiprazole, which is better known to the public as the prescription medication Abilify. Manufactured by both Bristol-Myers Squibb Co. and Otsuka America Pharmaceuticals Inc., Abilify is available in a variety of forms including oral tablets, an oral solution, or as an injection solution for intramuscular injection. Used to treat schizophrenia and more recently approved for bipolar disorder and depression, Abilify is certainly not without its share of potentially serious side effects.

First of all, it is important to understand that the risk of suicidal thoughts and suicidal behavior, especially in adolescents and young adults is much more prevalent in patients that have been using any kind of anti-depressant medication, Abilify included. Because of this, it is recommended that Abilify only be taken by those that are at least 24 years of age or older.  Prescribing the drug to someone younger than that may be medical malpractice.  And prescribing the drug Abilify without prescribing other drugs first, may be medical malpractice.  Abilify should only be prescribed as a last resort and with great care.

It is also important to note that an increased mortality rate has been seen amongst dementia patients who use prescription anti-depressants or antipsychotics, including the drug Abilify. Evidence can be seen in this from the results of 10-week clinical trial where it was found that the rate of death amongst those who had been treated with an anti-depressant was almost 2% higher than those who had only taken a placebo; researchers say this is particularly prevalent amongst elderly women.

Other studies have revealed even more dangers associated with Abilify and other antipsychotics and anti-depressant medication. This includes an increased risk of stroke, Hyperglycemia and Diabetes Mellitus amongst elderly patients, as well.

The best thing that you or a loved one can do before taking any kind of medication, whether it is over-the-counter or prescription is to properly educate yourself on the drug; no matter how innocent it may seem. For some it is too late, however – and if you or someone you know has suffered from any of the serious side effects that are associated with the drug Abilify, it is important that you seek out the appropriate legal help immediately.

Court cases dealing with potential death as a result of Abilify or any other drug are an important matter, and this is a legal issue that requires the serious and professional attention of a fully-qualified Abilify attorney. Fill out our form below for a free case evaluation and analysis by experienced attorneys working on Abilify lawsuits. 

Keywords: Abilify | Abilify Tardive Dyskinesia | Abilify Attorneys | Abilify Lawsuit | Abilify Law Firm
 

Free Case Evaluation

Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.

Your Name:
Your Address:
Your City:
Your State:
Your Zipcode:
Your Email:
Your Phone Number:
Your Fax Number:
Date of Injury:  
Location of Injury:  
If this inquiry is not for yourself, please tell us the name of the person injured:
Your relationship to this person:
 
Details of Injury:
   
Enter the code shown:

Please note, this form may take a few seconds to process after the Submit Case button is pressed.
 


Abilify In the News

US FDA Approves Dual-Chamber Syringe for Abilify Maintena ® (aripiprazole ... - Business Wire (press release)
US FDA Approves Dual-Chamber Syringe for Abilify Maintena ® (aripiprazole ...Business Wire (press release)PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc....
More Information »



FDA Approves New Formulation for Abilify Maintena - Monthly Prescribing Reference
FDA Approves New Formulation for Abilify MaintenaMonthly Prescribing ReferenceOtsuka and Lundbeck announced that the Food and Drug Administration (FDA) has approved Abilify Maintena (aripiprazole) for extended-release...
More Information »



FDA to Review Aripiprazole Lauroxil NDA for Schizophrenia - Monthly Prescribing Reference
FDA to Review Aripiprazole Lauroxil NDA for SchizophreniaMonthly Prescribing ReferenceThe NDA filing included positive results from the randomized, multicenter, double-blind, placebo-controlled Phase 3 study assessing the...
More Information »



Morning Break: Hitch in U.S. Ebola Case, Doc $$ - MedPage Today
MedPage TodayMorning Break: Hitch in U.S. Ebola Case, Doc $$MedPage TodayA prefilled syringe containing Abilify Maintena, a long-acting form of the antipsychotic drug aripiprazole, won FDA approval, its manufacturers said....
More Information »



FDA to review Otsuka and Lundbeck's potential schizophrenia game changer - BioPharma Dive
BioPharma DiveFDA to review Otsuka and Lundbeck's potential schizophrenia game changerBioPharma DiveIf approved, this could be a game changer for Otsuka, whose popular antipsychotic Abilify (aripiprazole) saw $1.03...
More Information »



Savvy Senior: Generic drugs offer seniors big savings - Pomerado Newspaper Group
Savvy Senior: Generic drugs offer seniors big savingsPomerado Newspaper GroupTo gain approval from the U.S. Food and Drug Administration (FDA), generic drugs are required to the same active ingredient, strength, dosage form...
More Information »



Savvy Senior: Off-brand drugs can offer seniors some big savings - Yuma Sun
Savvy Senior: Off-brand drugs can offer seniors some big savingsYuma SunTo gain approval from the U.S. Food and Drug Administration (FDA), generic drugs are required to the same active ingredient, strength, dosage form and...
More Information »



Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.? - Motley Fool
Motley FoolBetter Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?Motley FoolBy 2015, Bristol-Myers will also be staring down the exclusivity loss of schizophrenia drug Abilify, which is on pace to deliver...
More Information »



Stock Update (NYSE:BMY): Bristol immunotherapy gets 6-month U.S. FDA ... - Jutia Group
Stock Update (NYSE:BMY): Bristol immunotherapy gets 6-month U.S. FDA ...Jutia GroupThe company's principal products are virology products comprising Baraclude, Reyataz, and Sustiva; oncology products, including Erbitux,...
More Information »



Lundbeck får godkendt nyt kanylesystem til Abilify Maintena - EuroInvestor.com
Lundbeck får godkendt nyt kanylesystem til Abilify MaintenaEuroInvestor.comLundbeck og Otsuka ansøgte tidligere i år FDA om godkendelse af en udvidet etikettering af Abilify Maintena, der skal gøre midlet anvendeligt til...
More Information »



Die Maske des Ministers - APOTHEKE ADHOC
Die Maske des MinistersAPOTHEKE ADHOCRabattvertrag für Reimport: Die AOK Rheinland-Hamburg und die AOK Nordost haben für Abilify Vereinbarungen mit Kohl, Milinda und Heptagon geschlossen. Foto: APOTHEKE ADHOC. Schnell noch...
More Information »



Aktier/åbning: Novo siver fra rekordniveau - EuroInvestor.com
Aktier/åbning: Novo siver fra rekordniveauEuroInvestor.comDet danske aktiemarked åbner lidt højere tirsdag, hvor stemningen på de internationale finansmarkeder i høj grad er præget af demonstrationer i Hongkong, der skaber en...
More Information »



Aktier/middag: Lettelse over aflyst catalansk afstemning - EuroInvestor.com
Aktier/middag: Lettelse over aflyst catalansk afstemningEuroInvestor.comLundbecks japanske partner, Otsuka, har hos de amerikanske sundhedsmyndigheder (FDA) fået godkendt en to-kammer kanyle til injektion af skizofrenimidlet...
More Information »



Sværvægtsaktier holdt C20 i skak - Børsen Online
Børsen OnlineSværvægtsaktier holdt C20 i skakBørsen OnlineAktien lukkede i 159,80 efter et fald på 0,8 pct. Lundbecks japanske partner, Otsuka, har hos de amerikanske sundhedsmyndigheder (FDA) fået godkendt en to-kammer...
More Information »



2014最受赞赏的中国医药制造业公司 - 生物谷
2014最受赞赏的中国医药制造业公司生物谷今年的“最受赞赏的中国公司”全明星榜上,阿里巴巴又一次登顶。平均每13位受访高管就有一人把票投给这家被全球资本市场关注的中国公司。同时,榜单的结果也微妙地体现出我们本地企业家的品质:不以势取人。一部分面对挑 ...and more »
More Information »

 









 
Aviation Accidents| Car Accidents| Truck Accidents| Birth Injuries| Nursing Home Negligence| Mesothelioma| Defective Medical Devices
Copyright 2011 The Personal Injury Center of AmericaTM All Rights Reserved.
The Personal Injury Center of AmericaTM is proud to serve clients in New York, Los Angeles, Chicago, Houston, Philadelphia, and throughout the nation.